Cargando…

Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study

BACKGROUND: Patients in pediatric intensive care Units (PICU) are susceptible to infections with antibiotic resistant organisms which increase the morbidity, mortality and cost of care. To describe the clinical characteristics and mortality in patients with Multi-Drug Resistant (MDR) gram negative o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqui, Naveed-ur-Rehman, Qamar, Farah Naz, Jurair, Humaira, Haque, Anwarul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262978/ https://www.ncbi.nlm.nih.gov/pubmed/25430979 http://dx.doi.org/10.1186/s12879-014-0626-9

Ejemplares similares

Mortality patterns among critically ill children in a Pediatric Intensive Care Unit of a developing country
por: Siddiqui, Naveed-ur-Rehman, et al.
Publicado: (2015)

Abstract to publication conversion in pediatric critical care medicine in Pakistan
por: Haque, Anwarul, et al.
Publicado: (2021)

Impact of pharmacist-led antibiotic stewardship program in a PICU of low/middle-income country
por: Haque, Anwarul, et al.
Publicado: (2018)

Polymyxin E–Resistant Gram-Negative Bacteria in Tunisia and Neighboring Countries: Are There Commonalities?
por: Dziri, Olfa, et al.
Publicado: (2021)

Burden of neurological illnesses in a pediatric intensive care unit of developing country
por: Abbas, Qalab, et al.
Publicado: (2014)

Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis
por: Lu, Difan, et al.
Publicado: (2023)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children
por: Jia, Xuedong, et al.
Publicado: (2022)

Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study
por: Liu, Jiao, et al.
Publicado: (2022)

Antimicrobial Peptides for Gram-Negative Sepsis: A Case for the Polymyxins
por: David, Sunil A.
Publicado: (2012)

Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria
por: Deris, Zakuan Z., et al.
Publicado: (2014)

Low-dose polymyxin: an option for therapy of Gram-negative sepsis
por: Harm, Stephan, et al.
Publicado: (2016)

Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
por: Bergen, Phillip J., et al.
Publicado: (2015)

Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics
por: Vaara, Martti
Publicado: (2019)

Frequency of Pediatric Acute Respiratory Distress Syndrome Based on Oxygen Saturation Index in Pediatric Intensive Care Unit of a Developing Country
por: Ahmed, Rahim, et al.
Publicado: (2019)

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections
por: Xia, G. L., et al.
Publicado: (2021)

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
por: Wang, Peile, et al.
Publicado: (2021)

Outcome of pediatric procedural sedation & analgesia in a tertiary care hospital in Pakistan
por: Jurair, Humaira, et al.
Publicado: (2015)

Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens
por: Tran, Thien B., et al.
Publicado: (2018)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
por: Wu, Zhenping, et al.
Publicado: (2023)

SuperPolymyxin™ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples
por: Przybysz, Sara M., et al.
Publicado: (2018)

Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
por: Garg, Suneel Kumar, et al.
Publicado: (2017)

Evaluation of resazurin-based assay for rapid detection of polymyxin-resistant gram-negative bacteria
por: Jia, Huaiyu, et al.
Publicado: (2020)

Evaluation of the Clinical Systems for Polymyxin Susceptibility Testing of Clinical Gram-Negative Bacteria in China
por: Zhu, Ying, et al.
Publicado: (2021)

Rapid and sensitive detection of gram-negative bacteria using surface-immobilized polymyxin B
por: Kang, Hyun-Jin, et al.
Publicado: (2023)

Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
por: Choe, Junsu, et al.
Publicado: (2019)

Vancomyxins: Vancomycin-Polymyxin Nonapeptide Conjugates That Retain Anti-Gram-Positive Activity with Enhanced Potency against Gram-Negative Strains
por: van Groesen, Emma, et al.
Publicado: (2021)

Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock
por: Ramasubban, Suresh, et al.
Publicado: (2008)

Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
por: Velkov, Tony, et al.
Publicado: (2014)

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
por: Draper, Lorraine A, et al.
Publicado: (2013)

Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B
por: Krzyzanski, Wojciech, et al.
Publicado: (2017)

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia
por: Biagi, Mark, et al.
Publicado: (2019)

Coarse-grained simulations uncover Gram-negative bacterial defense against polymyxins by the outer membrane
por: Jiang, Xukai, et al.
Publicado: (2021)

Polymyxin B in Combination with Glycerol Monolaurate Exerts Synergistic Killing against Gram-Negative Pathogens
por: Zheng, Yun, et al.
Publicado: (2022)

A method for increasing electroporation competence of Gram-negative clinical isolates by polymyxin B nonapeptide
por: Qin, Jilong, et al.
Publicado: (2022)

Outcome of Using Intraventricular Plus Intravenous Polymyxin B in Post-neurosurgical Patients With Multi/Extensively Drug-Resistant Gram-Negative Bacteria-Induced Intracranial Infection
por: Li, Hangyang, et al.
Publicado: (2022)

Gram-negative bacteremia is an independent predisposing factor for critical illness polyneuromyopathy
por: Kritikos, K, et al.
Publicado: (2007)

Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis
por: Yuk, Simseok A., et al.
Publicado: (2021)

Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection
por: Li, Xueyong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_utdqr76adgp52omoc5gu9i4kpg